Built from thickets of glucose, galactose, mannose and more, the glycome plays key roles in cell communication, immunity and ...
The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...
Scientists at MIT have discovered that a little-known protein called intelectin-2 plays a powerful double role in defending ...
But because they penetrate more slowly and even more shallowly than AHAs, they typically cause less irritation and are often ...
IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. For decades, the "gut-kidney axis" hypothesis has suggested that the ...
Vertex Pharmaceuticals has a rolling biologics license application with the FDA for povetaciceptin IgA nephropathy. With new ...
Vertex reported a phase 3 win for its kidney disease prospect povetacicept, meeting analyst expectations and firing the starting gun on a race to the FDA that could result in an accelerated approval ...
Meltability of cheese is one of the most researched properties, write Prateek Sharma, Ph.D., and Nitin Joshi, Ph.D. Among all ...
A NOVEL therapeutic approach targeting the cytokine A Proliferation-Inducing Ligand (APRIL) may significantly reduce proteinuria and disease activity in patients with IgA nephropathy, according to ...
Povetacicept significantly reduced proteinuria in patients with IgA nephropathy in the RAINIER trial, supporting an upcoming FDA submission.
Leerink Global Healthcare Conference 2026 March 10, 2026 1:00 PM EDTCompany ParticipantsUptal Patel - Chief Medical ...
Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results